IMUGENE CHART. TA only, page-18685

Imugene announced on 23/12/20 ( sp at 10.5 c) some of the details of the deal Mr Hopper via Moreglade P/L entered into with Macquarie Bank. The funding agreement used 107M shares as security for a facility with a 3 year term , ie expiring December 23. What is not specified is how much Mr. Hopper has received as payment for his loan of shares and most importantly what has been done with those shares since the facility was established. It would be a reasonable assumption that they have been pushed into the market as an instrument to push pricing down, given the unexplained share price fall beginning late last year, but ultimately it’s an unknown. What is known is that by opening the facility, a large and powerful bank has its hands on 107M shares for 3 years.
It would be a very welcome move for PH to finalise the facility, bring back in whatever residual shares are left and reassure the market that it is not possible that any of the shares he controls could possibly be used to short sell. Imugene would do very well to provide a little more explanation and comfort to shareholders of some of the finer details of major corporate moves that take place, the lack of explanation is unsettling, and basically unnecessary.